XML 19 R8.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Cash flows from operating activities:    
Net income $ 22,411 $ 22,632
Adjustments to reconcile net income to net cash provided by operating activities:    
Provision for credit losses 3,444 3,012
Depreciation and amortization 5,251 4,075
Net amortization on securities 696 1,218
Amortization (accretion) of net premium/discount on purchased loans 19 (6)
Amortization of investments in tax credit funds 279 415
Loss on sale of securities, net 0 403
Deferred income tax expense (benefit) 1,180 (2,583)
Stock-based compensation expense 1,815 2,079
Originations of mortgage loans held for sale (36,616) (44,392)
Proceeds from mortgage loans held for sale 36,648 35,887
Gain on mortgage loans held for sale (960) (964)
MSR asset valuation adjustment 0 (450)
Gain on sale of MSR asset 0 (410)
Net gain on disposals of premises and equipment (75) (2)
Increase in the cash surrender value of life insurance (389) (229)
Employee Retention Credit received 1,863 0
Net losses on sales and write-downs of other real estate owned 515 21
Net change in operating leases 275 35
Decrease in other assets 2,486 4,835
(Decrease) increase in other liabilities (3,279) 1,557
Net cash provided by operating activities 35,563 27,133
Cash flows from investing activities:    
Purchases of securities available for sale (72,377) (7,194)
Maturities and pay downs of securities available for sale 27,183 42,046
Proceeds from sales and calls of securities available for sale 5,504 21,224
Redemption of non-marketable equity securities held in other financial institutions 0 5,556
Purchase of non-marketable equity securities held in other financial institutions (34) (4,016)
Originations of mortgage warehouse loans (1,931,472) (1,842,251)
Proceeds from pay-offs of mortgage warehouse loans 1,876,421 1,771,222
Net decrease (increase) in loans, excluding mortgage warehouse and loans held for sale 40,496 (160,209)
Purchase of other intangibles (2,500) 0
Proceeds from sale of the MSR asset 0 15,885
Proceeds from bank-owned life insurance 208 0
Return of capital and other distributions from limited partnership investments 182 275
Capital calls on limited partnership investments (2,217) (388)
Purchases of premises and equipment (753) (3,906)
Proceeds from sales of premises and equipment 111 18
Proceeds from sales of other real estate owned 1,213 54
Net cash used in investing activities (58,035) (161,684)
Cash flows from financing activities:    
Net increase in deposits 115,292 254,339
Repayments of long-term FHLB advances (70) (68)
Proceeds from short-term FHLB advances 116,724 670,000
Repayments of short-term FHLB advances (116,724) (740,000)
Redemption/Repurchase of subordinated debentures (72,593) (33,675)
Net increase (decrease) in securities sold under agreements to repurchase 98 (372)
Dividends paid (4,752) (4,670)
Cash received from exercise of stock options 450 68
Net cash provided by financing activities 38,425 145,622
Net increase in cash and cash equivalents 15,953 11,071
Cash and cash equivalents at beginning of period 470,249 280,441
Cash and cash equivalents at end of period 486,202 291,512
Interest paid 55,476 61,707
Income taxes paid (refund) 1,346 (2,069)
Significant non-cash transactions:    
Recognition of operating right-of-use assets 546 491
Recognition of operating lease liabilities 515 500
Impairment of right-of-use assets due to branch closures $ (332) $ 0